Cisatracurium (NIMBEX®) - The 'ideal' neuromuscular blocking drug? Histamine release and serum tryptase;Cisatracurium - Ein Stereoisomer als 'ideales' Relaxans? Histaminfreisetzung und Tryptasebestimmung nach Bolusapplikation von Cisatracurium: Ein Vergleich mit Vecuronium

Anaesthesist

Volumn 46, Issue 6, 1997, Pages 486-491

  Soukup, J ^a,b   Doenicke, A ^a,d   Hoernecke, R ^a   Moss, J ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY OF CHICAGO   (United States)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

cisatracurium; histamine release; muscle relaxants; serumtryptase

Indexed keywords

ATRACURIUM; ATRACURIUM BESILATE; CISATRACURIUM; HISTAMINE; ISOFLURANE; LORMETAZEPAM; NITROUS OXIDE; THIOPENTAL; TRYPTASE; VECURONIUM; CHYMASE; CHYMASE 2; DRUG DERIVATIVE; NEUROMUSCULAR BLOCKING AGENT; SERINE PROTEINASE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HUMAN; MAJOR CLINICAL STUDY; MUSCLE RELAXATION; NEUROMUSCULAR BLOCKING; PRICK TEST; RANDOMIZED CONTROLLED TRIAL; BLOOD; BLOOD PRESSURE; COMPARATIVE STUDY; HEART RATE; HISTAMINE RELEASE; INTRAVENOUS ANESTHESIA; INTRAVENOUS DRUG ADMINISTRATION;

ANESTHESIA, INTRAVENOUS; ATRACURIUM; BLOOD PRESSURE; CHYMASES; HEART RATE; HISTAMINE; HISTAMINE RELEASE; HUMANS; INJECTIONS, INTRAVENOUS; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR NONDEPOLARIZING AGENTS; SERINE ENDOPEPTIDASES; TRYPTASES; VECURONIUM BROMIDE;

EID: 0030612771     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001010050428     Document Type: Article

References (25)

1. Boileau S, Hummer-Sigiel M, Moeller R, Drouet N (1985) Réévaluation des risques respectifs d'anaphylaxie et d'histaminolibération avec les substances anesthésiologiques. Ann Fr Anesth Réanim 4:195-200
2. Cannon JE, Fahey MR, Moss J, Miller RD (1988) Vecuronium: the effect of large intravenous dose on plasma histamine. Can J Anesth 35:350-353
3. Clayton DG, Watkins J (1984) Histamine release with vecuronium (letter). Anaesthesia 39:1143-1144
4. Doenicke A, Moss J, Lorenz W, Hoernecke R (1995) Morphine IV and nalbuphine IV cause histamine and catecholamine increase without relevant hemodynamic changes. Clin Pharmacol Ther 58:81-89
5. Doenicke A, Moss J, Lorenz W, Hoernecke R, Gottardis M (1994) Are hypotension and rash after atracurium really caused by histamine release? Anesth Analg 78:967-972
6. Doenicke A, Moss J, Lorenz W, Mayer M, Rau J, Jedrzejewski A, Ostwald P (1996) Effect of oral antihistamine premedication on Mivacurium-induced histamine release and side effects. Br J Anaesth 77:421-423
7. Doenicke A, Soukup J, Hoernecke R, Moss J (1997) The lack of histamine release of cisatracurium: A double-blind comparison with vecuronium. Anesth Analg 84:623-628
8. Futo J, Kupferberg JP, Moss J, Fahey MR, Cannon JE, Miller RD (1988) Vecuronium - inhibits Histamine N-Methyltransferase. Anesthesiology 69:92-96
9. ™) and vecuronium in patients with coronary artery disease. Anesth Analg 81:1010-1014
10. Laroche D, Lefrancois C, Gerard JL, Dubois F, Vergnaud MC, Guéant JL, Bricard H (1992) Early diagnosis of anaphylactic reactions to neuromuscular blocking drugs. Br J Anaesth 69:611-614
11. Laroche D, Vergnaud MD, Sillard B, Soufarapis H, Bricard H (1991) Biochemical markers of anaphylactoid reactions to drugs. Anesthesiology 75:945-949
12. Laroche D, Dubois F, Lefrancois C, Gerrard JL, Bricard H (1992) Plasma tryptase concentration is related to the severity grade of the anaphylactoid reaction. Anesthesiology 77:A1108
13. Lavery GG, Hewitt AJ, Kenny NT (1985) Possible histamine release after vecuronium. Anaesthesia 40:389-390
14. Lavery GG, Clarke RSJ, Watkins J (1986) Histaminoid response after intradermal and intravenous administration of atracurium, vecuronium and tubocurarine: a comparative study. Eur J Anaesthesiol 3:439-447
15. Laxenaire MC (1993) Drugs and other agents involved in anaphylactic shock occurring during anesthesia. A french multicenter epidentiological inquiry. Ann Fr Anesth Reanim 12:91-96
16. Lepage JY, Malinowsky JM, Malinge M, Cozian A, Pinaud M (1994) Pharmacodynamics and histamine releasing protency to high dose of 51W89. Anesthesiology 81:A1077
17. Leynadier F, Sansarricq M, Didier JM, Dry J (1987) Prick tests in the diagnosis of anaphylaxis to general anaesthetics. Br J Anaesth 59:683-689
18. Lien CA, Belmont MR, Abalos A, Eppich L, Quessy S, About-Donia MM, Savarese JJ (1995) The cardiovascular effects and histamine releasing properties of 51W89 in patients receiving nitrous/opioid/barbiturate anesthesia. Anesthesiology 81:1131-1138
19. Lorenz W, Duda D, Dick W, Sitter H, Doenicke A, Black A, Weber D, Menke H, Stinner B, Junginger T, Rothmund M, Ohmann C, Healy MJR (1994) Incidence and clinical importance of perioperative histamine release: randomised study of volume loading and anti-histamines after induction anaesthesia. Lancet 343:933-940
20. Marone G, Stellato C, Matronardi P, Mazzarella B (1993) Mechanisms of activation of human mast cells and basophils by general anaesthetic drugs. Ann Fr Anesth Reanim 12:116-125
21. Moss J, Philbin MD, Rosow CE, Basta SJ, Gelb C, Savarese JJ (1982) Histamine release by neuromuskular blocking agents in man. Klin Wochenschr 60:891-895
22. Schwartz LB (1990) Tryptase, a mediator of human mast cells. J Allerg Clin Immunol 86:594-598
23. Soukup J, Doenicke A, Hoernecke R, Vorhammer B, Seebauer A, Moss J (1996) Kardiovaskuläre Effekte nach Bolusapplikation von Cisatracurium: Ein Vergleich mit Vecuronium. Anaesthesist 45:1024-1029
24. Tryba M, Triene M, Wruck G, Zenz M (1988) Kardiovaskuläre Reaktionen und Histaminfreisetzung nach Atracurium - ein Problem der Dosis? Anaesthesist 37:483-488
25. Wastilla WB, Maehr RB, LaMunion GL, Belmont MR, Savarese JJ (1996) Preclinical pharmacology of cisatracurium besylate. Curr Opin Anesth [Suppl 1]9:2-8